human | Q5 |
P496 | ORCID iD | 0000-0002-8688-880X |
P69 | educated at | Chalmers University of Technology | Q836805 |
P108 | employer | Sahlgrenska University Hospital | Q3290496 |
Integrative Research Laboratories | Q61932255 | ||
P734 | family name | Waters | Q1175589 |
Waters | Q1175589 | ||
Waters | Q1175589 | ||
P735 | given name | Susanna | Q14936808 |
Susanna | Q14936808 | ||
P106 | occupation | researcher | Q1650915 |
Q96814686 | (3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) - a novel cortical-preferring catecholamine transmission- and cognition-promoting agent |
Q39084168 | In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. |
Q71963261 | On the Quantitative Structure-Activity Relationships of Meta-Substituted (S)-Phenylpiperidines, a Class of Preferential Dopamine D2 Autoreceptor Ligands: Modeling of Dopamine Synthesis and Release in Vivo by Means of Partial Least Squares Regression |
Q94482127 | Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease |
Search more.